logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Cancer cover

Cancer

IF5.1
Papers20464
Citations62240
Journal Papers 21151
Publication Date
delete
Trends in sociodemographic factors associated with human papillomavirus vaccine hesitancy in the United States: 2010–2022
deleteCancer
IF5.1
delete2026-09-29
delete0
deleteOAAI
deleteDina K. Abouelella BDS, MPH, CPH; Mrudula Nair BDS, MPH; Mary A. Gerend PhD; Olivia Aspiras PhD; Nosayaba Osazuwa-Peters BDS, PhD, MPH, CHES; Eric Adjei Boakye PhD
deleteShare
deleteSave
Study raises important questions about the clinical utility of multicancer early detection testing
deleteCancer
IF5.1
delete2026-09-29
delete0
deleteOAAI
deleteLeah Lawrence
deleteShare
deleteSave
Tile-based radiation therapy may be new standard of care for patients with surgical brain metastases
deleteCancer
IF5.1
delete2026-09-29
delete0
deleteOAAI
deleteLeah Lawrence
deleteShare
deleteSave
Progression-free survival and overall survival in the first-line treatment of BRCA wild-type advanced epithelial ovarian cancer: An analysis of patient-level data pooled from historical clinical trials
deleteCancer
IF5.1
delete2026-09-29
delete0
PREAI
deleteLe Su MD, PhD; Mehmet Burcu PhD, FISPE; Kayleen Ports MS; Vlad Gradinariu MS; Yahav Itzkovich BA; Rahul Jain PhD; Karin Yamada MD; Cumhur Tekin MD; Lei Chen PhD
deleteShare
deleteSave
Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025
deleteCancer
IF5.1
delete2026-09-29
delete0
PREAI
deleteNarjust Florez MD; Sandip Pravin Patel MD; Ravi Salgia MD, PhD; Jacob Sands MD; Erin L. Schenk MD, PhD; Elaine Shum MD; Mihaela Aldea MD, PhD; Christine M. Bestvina MD; Jessica Donington MD, MSCR; Christine A. Garcia MD, MPH; Jorge Nieva MD; David R. Gandara MD; Balazs Halmos MD, MS; Fred R. Hirsch MD, PhD; Xiuning Le MD, PhD; Percy Lee MD; Jyoti Malhotra MD, MPH; Tejas Patil MD; Solange Peters MD, PhD; Jonathan Wesley Riess MD, MS; Julia Rotow MD; Fawzi Abu Rous MD; Joshua Sabari MD; Triparna Sen PhD, MS; Eric K. Singhi MD; Ana I. Velázquez MD, MSc; Heather A. Wakelee MD; Edward S. Kim MD, MBA
deleteShare
deleteSave
Interpreting a borderline signal in colorectal cancer screening among sexual and gender minority adults
deleteCancer
IF5.1
delete2026-09-27
delete0
PREAI
deleteChristos Zavos MD, PhD
deleteShare
deleteSave
Recommendations of the American Cancer Society workshop on design, conduct, analysis, and reporting of multicancer early detection trials with late-stage incidence end points and post-trial ongoing evaluation—The Peachtree Consensus
deleteCancer
IF5.1
delete2026-09-27
delete0
deleteOAAI
deleteRuth Etzioni PhD; Larry Kessler ScD; Deb Schrag MD, MPH; Peter Sasieni PhD; Hilary A. Robbins PhD; Hormuzd A. Katki PhD; Stephen W. Duffy PhD; Roman Gulati MS; Diana Buist PhD; Sean Tunis MD, MSc; Rebecca Landy PhD; Jane Lange PhD; Alpa V. Patel PhD; William L. Dahut MD; Robert A. Smith PhD
deleteShare
deleteSave
Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy
deleteCancer
IF5.1
delete2026-09-27
delete0
PREAI
deleteOded Icht MD; Inbar Nardi-Agmon MD; Paaladinesh Thavendiranathan MD, SM; Shaf Keshavjee MD; Amiya Agrawal MD; John-Michael Miro MD; Omar Badran MD; Geoffrey Liu MD; Xiang Y. Ye Msc; B. C. John Cho MD, PhD; Andrea Bezjak MD; Andrew Hope MD
deleteShare
deleteSave
Toward a globally integrated histologic risk classification of pretreated Wilms tumor
deleteCancer
IF5.1
delete2026-09-25
delete0
PREAI
deleteFilippo Spreafico MD; Arnauld Verschuur MD
deleteShare
deleteSave
Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis
deleteCancer
IF5.1
delete2026-09-25
delete0
deleteOAAI
deleteRussell Leong BHSc; David Chen MD; Laith Almasri BSc; Nicholas Lum BHSc; Karren Xiao BHSc; Maryam Soleimani MD; Christian K. Kollmannsberger MD; Srinivas Raman MD, MASc
deleteShare
deleteSave
Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis
deleteCancer
IF5.1
delete2026-09-25
delete0
deleteOAAI
deleteHira Mian MD, MSc; Muhammad Salman Faisal MD; Tiening Chen MS; Ruta Brazauskas PhD; Temitope Oloyede MS; Nausheen Ahmed MD; Aimaz Afrough MD; Larry D. Anderson MD, PhD; Rahul Banerjee MD, FACP; Jesus Berdeja MD; Aram Bidikian MD; Jakob Devos BS; Binod Dhakal MD; Ajoy Dias MD; Danai Dima MD; Yvonne A. Efebera MD, MS; Lohith Gowda MD; Doris K. Hansen MD; Hamza Hashmi MD; Heather J. Landau MD; Lazaros Lekakis MD; Abu-Sayeef Mirza MD, MPH; Ravi Narra MS; Krina Patel MD, MSc; Ashley E. Rosko MD; Mark Schroeder MD; Surbhi Sidana MD; Saad Usmani MD, FACP; Marcelo C. Pasquini MD, MS; Taiga Nishihori MD; Othman Salim Akhtar MD; Meera Mohan MD, MS
deleteShare
deleteSave
Outcome after first relapse post-immunochemotherapy in older adults with Philadelphia-negative B-cell acute lymphoblastic leukemia: A GRAALL study
deleteCancer
IF5.1
delete2026-09-24
delete0
PREAI
deletePerrine Moyer MD; Thibaut Leguay MD; Maxime Jullien MD, PhD; Françoise Huguet MD; Gabrielle Roth-Guepin MD; Yosr Hicheri MD; Amine Belhabri MD; Thomas Cluzeau MD, PhD; Ana Berceanu MD; Emmanuelle Tavernier MD; Stéphane Leprêtre MD; Karin Bilger MD; Pascal Turlure MD; Jean-Noel Bastié MD, PhD; Marie Balsat MD; Magda Alexis MD; Eolia Brissot MD, PhD; Delphine Lebon MD; Emmanuel Raffoux MD; Stefan Wickenhauser MD; Victoria Cacheux MD; Anne Banos MD; Sarah Bonnet MD; Nicolas Boissel MD, PhD; Hervé Dombret MD; Philippe Rousselot MD, PhD; Patrice Chevallier MD, PhD
deleteShare
deleteSave
Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial
deleteCancer
IF5.1
delete2026-09-21
delete0
deleteOAAI
deleteStine Ulrik Mikkelsen MD, PhD; Ali Al-Mousawi MD; Amalie Bach Puglisi MD; Anders Pommer Vallentin MD; Astrid Østergaard Mortensen BSc; Zachary Madaj MSc; Toshinori Hinoue MSc, PhD; Heidi Naomi Ottesen BSc; Jakob Schmidt Jespersen MSc, PhD; Linn Gillberg MSc, PhD; Morten Tulstrup MD, MSc, PhD; Niels Richard Hansen MSc; Jakob Werner Hansen MD, PhD; Mette Klarskov Andersen MD, DMSc; Stacey Lyn Thomas MSc, PhD; Christine Isaguirre BSc; Ryan Sheldon MSc, PhD; Marie Adams MSc; Ryan Burgos BSc; Stephen Baylin MD; Bo Kok Mortensen MD, PhD; Casey Lee O’Connell MD; Marianne Tang Severinsen MD, PhD; Peter William Laird PhD; Jens Lykkesfeldt PhD, DMSc; Peter Jones PhD, DSc; Kirsten Grønbæk MD, DMSc
deleteShare
deleteSave
Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children’s Oncology Group AREN0532, AREN0533, and AREN03B2 studies
deleteCancer
IF5.1
delete2026-09-18
delete0
PREAI
deleteNicholas F. Evageliou MD; Lindsay A. Renfro PhD; Kelly L. Vallance MD; Carly R. Varela MD; Daniel J. Benedetti MD, MA; Nicholas G. Cost MD; Peter F. Ehrlich MD; John A. Kalapurakal MD; Geetika Khanna MD; Jennifer H. Aldrink MD; Richard D. Glick MD; Michael V. Ortiz MD; Lauren N. Parsons MD; Arnold C. Paulino MD; Maddy Artunduaga MD; Ethan A. Smith MD; David B. Dix MBChB; Conrad V. Fernandez MD; Jeffrey S. Dome MD, PhD; James I. Geller MD; Elizabeth A. Mullen MD
deleteShare
deleteSave
Outcomes of adult patients with Li-Fraumeni syndrome and myeloid neoplasms
deleteCancer
IF5.1
delete2026-09-18
delete0
deleteOAAI
deleteJayastu Senapati MD, DM; Hiam M. Abdel-Salam MS; Vladislav D. Jdanov MD; Sanam Loghavi MD; Ashley Woodson MS; Jessica Corredor MS; Gautam Borthakur MD; Naval G. Daver MD; Tapan M. Kadia MD; Koichi Takahashi MD, PHD; Yesid Alvarado MD; Naveen Pemmaraju MD; Uday R. Popat MD; Elizabeth J. Shpall MD; Farhad Ravandi MD; Florencia McAllister MD; Najat C. Daw MD; Guillermo Garcia-Manero MD; Banu K. Arun MD; Courtney D. DiNardo MD, MSCE
deleteShare
deleteSave
Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world study
deleteCancer
IF5.1
delete2026-09-16
delete0
PREAI
deleteMara Persano MD; Andrea Casadei-Gardini MD; Lorenzo Fornaro MD; Tomoyuki Satake MD, PhD; Oluseyi Abidoye MD; Federica Lo Prinzi MD; Lorenzo Antonuzzo MD; Jin Won Kim MD, PhD; Francesca Bergamo MD; Melanie Bathon MD; Anna Saborowski MD; Tiziana Pressiani MD; Caterina Vivaldi MD; Ilario Giovanni Rapposelli MD; Frederik Peeters MD; Chiara Braconi MD, PhD; David J. Pinato MD, PhD; Emiliano Tamburini MD; Monica Niger MD; Stefano Tamberi MD; Florian Castet MD; Monica Verrico MD; Alessandro Parisi MD; Nuno Couto MD; Hong Jae Chon MD, PhD; Angela Lamarca MD, PhD; Guido Giordano MD; Fabian Finkelmeier MD; Ester Oneda MD; Antonio Avallone MD; Lukas Perkhofer MD; Il Hwan Kim MD, PhD; Ingrid Garajova MD; Salvatore Corallo MD; Elisabetta Fenocchio MD; Emanuela Dell’Aquila MD; Chiara Pirrone MD; Lorenzo Lucidi MD; Giulia Tesini MD; Elena Valenzi MD; Anna Diana MD; Changhoon Yoo MD, PhD; Marta Schirripa MD; Vincenzo Formica MD; Maria Grazia Rodriquenz MD; Mario Scartozzi MD; Jorge Adeva MD; Michele Ghidini MD; Gerald W. Prager MD; Giuseppe Aprile MD; Gian Paolo Spinelli MD; Su Yung-Yeh MD, PhD; Stephen L. Chan MD; Masafumi Ikeda MD; Tanios Bekaii-Saab MD; Jessica Lucchetti MD; Daniele Lavacchi MD; Minsu Kang MD; Rita Balsano MD; Francesca Salani MD; Silvia Camera MD; Gianluca Masi MD; Sara Lonardi MD; Arndt Vogel MD, PhD; Lorenza Rimassa MD; Margherita Rimini MD
deleteShare
deleteSave
IMMU-NO versus yes: Applicability of immune checkpoint inhibitors in gynecologic cancers
deleteCancer
IF5.1
delete2026-09-16
delete0
PREAI
deleteWilliam B. Manning MD; Alicia M. Youssef MD; Oladapo O. Yeku MD, PhD
deleteShare
deleteSave
Effect of demographic characteristics on the outcome of prostate cancer salvage radiotherapy: Analysis from a randomized controlled trial
deleteCancer
IF5.1
delete2026-09-16
delete0
PREAI
deleteIsmaheel O. Lawal MD, PhD; Ashesh B. Jani MD; Subir Goyal PhD; Olayinka Abiodun-Ojo MD; Vishal Dhere MD; Sarah Bell MS, MPH; Pretesh Patel MD; Bruce Hershatter MD; Krishna Chaudhary MD; Aliza Mushtaq MD; Joseph Shelton MD; Sheela Hanasoge MD; Nikhil Sebastian MD; Sagar A. Patel MD; Raghuveer Halkar MD; Viraj A. Master MD; Ruth C. Carlos MD; David M. Schuster MD
deleteShare
deleteSave
Long-term patient-reported outcomes and toxicity following salvage radiotherapy for biochemical recurrence after radical prostatectomy
deleteCancer
IF5.1
delete2026-09-16
delete0
deleteOAAI
deleteConnor Lynch MD; Muzamil Arshad MD; Greeshma Rajeev-Kumar MD; Yan Che MS; Ted A. Skolarus MD; Parth K. Modi MD; Stanley L. Liauw MD
deleteShare
deleteSave
FDA adds vepdegestrant to options for ER-positive, HER2-negative, ESR1-mutated advanced breast cancer
deleteCancer
IF5.1
delete2026-09-16
delete0
deleteOAAI
deleteLeah Lawrence
deleteShare
deleteSave